Intarcia Therapeutics IPO

intarcia.com

Intarcia is a biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease.

Total Funding to Date$961.46MM
Register for Details

For more details on financing and valuation for Intarcia Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Intarcia Therapeutics Ticker Symbol

Intarcia Therapeutics does not have a ticker symbol because this company went bankrupt.

Intarcia Therapeutics Stock Price

The stock price for Intarcia Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Intarcia Therapeutics

New Enterprise Associates
GGV Capital
Venrock
Foresite Capital
Farallon Capital Management
Fred Alger Management
New Leaf Venture Partners
Quilvest
RA Capital

Intarcia Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/15/2016 Series EE $475.68MM raised $XXX.XX $XXX.XX
7/4/2014 Series DD $200MM raised $XXX.XX $XXX.XX
11/15/2012 Series CC $210MM raised $XXX.XX $XXX.XX
1/14/2010 Series BB-3 $7.87MM raised $XXX.XX $XXX.XX
4/28/2008 Series BB-2 $24.99MM raised $XXX.XX $XXX.XX
3/9/2007 Series BB-1 $23.84MM raised $XXX.XX $XXX.XX
12/1/2004 Series AA $19.08MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Intarcia Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector